A citation-based method for searching scientific literature

Sanjay Kalra, Kimi K Shetty, Vertivel B Nagarajan, Jignesh K Ved. Diabetes Ther 2020
Times Cited: 5







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
60

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
60

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
60

DPP-4 Inhibitor-Related Pancreatitis: Rare but Real!
J Hans DeVries, Julio Rosenstock. Diabetes Care 2017
18
40

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu,[...]. Lancet 2020
40

Practical recommendations for the management of diabetes in patients with COVID-19.
Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti, Geltrude Mingrone, David Hopkins, Andreas L Birkenfeld, Bernhard Boehm, Stephanie Amiel, Richard Ig Holt, Jay S Skyler,[...]. Lancet Diabetes Endocrinol 2020
313
40

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
40

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
40


Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
40


Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
492
40


Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control.
Young-Sun Lee, Hee-Sook Jun. Mediators Inflamm 2016
151
20

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
Marc Evans, Debbie Hicks, Dipesh Patel, Vinod Patel, Phil McEwan, Umesh Dashora. Diabetes Ther 2020
12
20

COVID-19 and diabetes: Can DPP4 inhibition play a role?
Gianluca Iacobellis. Diabetes Res Clin Pract 2020
143
20

Why are pregnant women susceptible to COVID-19? An immunological viewpoint.
Hong Liu, Li-Ling Wang, Si-Jia Zhao, Joanne Kwak-Kim, Gil Mor, Ai-Hua Liao. J Reprod Immunol 2020
133
20



SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report.
Katherine M Wang, Robert T Isom. Kidney Med 2020
8
20

DPP4 in Diabetes.
Diana Röhrborn, Nina Wronkowitz, Juergen Eckel. Front Immunol 2015
171
20


NF-κB signaling in inflammation.
Ting Liu, Lingyun Zhang, Donghyun Joo, Shao-Cong Sun. Signal Transduct Target Ther 2017
20

A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancers.
Azka Ali, Alejandra Fuentes, William Paul Skelton, Yu Wang, Susan McGorray, Chintan Shah, Rohit Bishnoi, Long H Dang, Nam H Dang. Mol Clin Oncol 2019
9
20


Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.
Lei Pan, Mi Mu, Pengcheng Yang, Yu Sun, Runsheng Wang, Junhong Yan, Pibao Li, Baoguang Hu, Jing Wang, Chao Hu,[...]. Am J Gastroenterol 2020
643
20

Endothelial cell infection and endotheliitis in COVID-19.
Zsuzsanna Varga, Andreas J Flammer, Peter Steiger, Martina Haberecker, Rea Andermatt, Annelies S Zinkernagel, Mandeep R Mehra, Reto A Schuepbach, Frank Ruschitzka, Holger Moch. Lancet 2020
20

Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis.
Christian Hampp, Richard S Swain, Casie Horgan, Elizabeth Dee, Yandong Qiang, Sarah K Dutcher, Andrew Petrone, Rong Chen Tilney, Judith C Maro, Catherine A Panozzo. Diabetes Care 2020
14
20


A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.
Keiji Kuba, Yumiko Imai, Shuan Rao, Hong Gao, Feng Guo, Bin Guan, Yi Huan, Peng Yang, Yanli Zhang, Wei Deng,[...]. Nat Med 2005
20


The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Wen Zhang, Yan Zhao, Fengchun Zhang, Qian Wang, Taisheng Li, Zhengyin Liu, Jinglan Wang, Yan Qin, Xuan Zhang, Xiaowei Yan,[...]. Clin Immunol 2020
573
20

COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
Luca Spiezia, Annalisa Boscolo, Francesco Poletto, Lorenzo Cerruti, Ivo Tiberio, Elena Campello, Paolo Navalesi, Paolo Simioni. Thromb Haemost 2020
310
20



Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.
Ka Shing Cheung, Ivan F N Hung, Pierre P Y Chan, K C Lung, Eugene Tso, Raymond Liu, Y Y Ng, Man Y Chu, Tom W H Chung, Anthony Raymond Tam,[...]. Gastroenterology 2020
523
20


Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, Yusen Zhou, Lanying Du. Cell Mol Immunol 2020
561
20

Coagulation abnormalities and thrombosis in patients with COVID-19.
Marcel Levi, Jecko Thachil, Toshiaki Iba, Jerrold H Levy. Lancet Haematol 2020
520
20

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Giacomo Grasselli, Alberto Zangrillo, Alberto Zanella, Massimo Antonelli, Luca Cabrini, Antonio Castelli, Danilo Cereda, Antonio Coluccello, Giuseppe Foti, Roberto Fumagalli,[...]. JAMA 2020
20

DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials.
Wenjia Yang, Xiaoling Cai, Xueyao Han, Linong Ji. Diabetes Metab Res Rev 2016
35
20

DPP4-directed therapeutic strategies for MERS-CoV.
Dirk Reinhold, Stefan Brocke. Lancet Infect Dis 2014
13
20

Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients.
Makoto Ayaori, Naotsugu Iwakami, Harumi Uto-Kondo, Hiroki Sato, Makoto Sasaki, Tomohiro Komatsu, Maki Iizuka, Shunichi Takiguchi, Emi Yakushiji, Kazuhiro Nakaya,[...]. J Am Heart Assoc 2013
88
20



Sex differences in immune responses.
Sabra L Klein, Katie L Flanagan. Nat Rev Immunol 2016
20

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.
Jia Liu, Ruiyuan Cao, Mingyue Xu, Xi Wang, Huanyu Zhang, Hengrui Hu, Yufeng Li, Zhihong Hu, Wu Zhong, Manli Wang. Cell Discov 2020
318
20

Laboratory Parameters of Hemostasis, Adhesion Molecules, and Inflammation in Type 2 Diabetes Mellitus: Correlation with Glycemic Control.
Eleonora Palella, Rossella Cimino, Salvatore A Pullano, Antonino S Fiorillo, Elio Gulletta, Antonio Brunetti, Daniela P Foti, Marta Greco. Int J Environ Res Public Health 2020
11
20

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
V Stalin Raj, Huihui Mou, Saskia L Smits, Dick H W Dekkers, Marcel A Müller, Ronald Dijkman, Doreen Muth, Jeroen A A Demmers, Ali Zaki, Ron A M Fouchier,[...]. Nature 2013
20

A dipeptidyl peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-proton pump exchanger-1 axis.
Haruya Kawase, Yasuko K Bando, Kazuyuki Nishimura, Morihiko Aoyama, Akio Monji, Toyoaki Murohara. J Mol Cell Cardiol 2016
17
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.